Literature DB >> 7552284

Mouse motor nerve terminal immunoreactivity to synaptotagmin II during sustained quantal transmitter release.

D Angaut-Petit1, P Juzans, J Molgó, L Faille, M J Seagar, M Takahashi, Y Shoji-Kasai.   

Abstract

An antibody directed against the lumenal NH2-terminus of synaptotagmin II was used to examine the distribution of this vesicular protein either after spontaneous acetylcholine release or after sustained release induced by La3+ or alpha-latrotoxin, in conditions that prevent endocytosis. The detection of the epitope was examined in the presence or absence of Triton X-100. We show that, in resting conditions of transmitter release, permeabilization of nerve terminal membranes is required for obvious detection of synaptotagmin Ii immunoreactivity whereas during sustained rates of quantal release, permeabilization is not necessary. These data indicate that, in the latter conditions, synaptotagmin II is incorporated into the terminal axolemma and its intravesicular domain exposed at the extracellular nerve terminal surface.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7552284     DOI: 10.1016/0006-8993(95)00294-z

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  A molecular basis underlying differences in the toxicity of botulinum serotypes A and E.

Authors:  Mark Bajohrs; Colin Rickman; Thomas Binz; Bazbek Davletov
Journal:  EMBO Rep       Date:  2004-11       Impact factor: 8.807

2.  Molecular landscape of BoNT/B bound to a membrane-inserted synaptotagmin/ganglioside complex.

Authors:  Jorge Ramirez-Franco; Fodil Azzaz; Marion Sangiardi; Géraldine Ferracci; Fahamoe Youssouf; Michel Robert Popoff; Michael Seagar; Christian Lévêque; Jacques Fantini; Oussama El Far
Journal:  Cell Mol Life Sci       Date:  2022-08-25       Impact factor: 9.207

3.  Synaptotagmin II immunoreactivity in normal and botulinum type-A treated mouse motor nerve terminals.

Authors:  P Juzans; J Molgo; L Faille; D Angaut-Petit
Journal:  Pflugers Arch       Date:  1996       Impact factor: 3.657

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.